Back to results
US 2020/0390870 A1Published application
Humanized anti-muc1* antibodies and direct use of cleavage enzyme
AssigneeMinerva Biotechnologies Corporation
InventorCynthia BAMDAD
Life of this patent
Estimating the term…
Abstract
The present application discloses humanized antibodies and antibody like proteins and fragments thereof and the use of proteolytic cleavage enzymes.
Claims26
A method for treating a patient diagnosed with cancer comprising administering directly to the patient, a MUC1 cleavage enzyme, alone or concurrent with an agent for treating cancer.
Dependencies are inferred from the claim text.